54.10
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RVMD Giù?
Forum
Previsione
Revolution Medicines Inc Borsa (RVMD) Ultime notizie
RVMD Stock Surge: Time to Reassess? - timothysykes.com
Can Revolution Medicines Inc. stock beat market expectations this quarterMarket Volume Report & AI Powered Trade Plan Recommendations - Trung tâm Dự báo KTTV quốc gia
The FDA Just Granted Its Speediest Review Ever. Disc Medicine, Others Fly. - Investor's Business Daily
Is Revolution Medicines Inc. stock a bargain at current levelsLayoff News & Expert Approved Momentum Trade Ideas - newser.com
Raymond James Raises Price Target for Revolution Medicines (RVMD) to $76 | RVMD Stock News - GuruFocus
Stocks making the biggest moves midday: Oracle, AST SpaceMobile, Revolution Medicines and more - CNBC
Revolution Medicines (RVMD) Stock Rises as Shares Surge 8.8% - GuruFocus
Revolution Medicines, Disc Medicine, American Express And Other Big Stocks Moving Higher On Friday - Benzinga
What earnings revisions data tells us about Revolution Medicines Inc.Quarterly Market Review & Smart Allocation Stock Tips - newser.com
Revolution Medicines (RVMD) Soars Over 11% in Stock Market Surge - GuruFocus
Revolution Medicines price target raised to $80 from $78 at BofA - TipRanks
Revolution Medicines stock surges after FDA grants priority voucher - Investing.com
Revolution Medicines stock surges after FDA grants priority voucher By Investing.com - Investing.com Australia
Wedbush Reiterates Outperform Rating for RVMD with $77 Price Tar - GuruFocus
Revolution Medicines receives FDA priority voucher for daraxonrasib By Investing.com - Investing.com South Africa
Revolution Medicines receives FDA priority voucher for daraxonrasib - Investing.com India
Revolution Medicines Receives FDA Voucher for Daraxonrasib - TipRanks
US FDA announces recipients of national priority vouchers - Reuters
Revolution Medicines Says Daraxonrasib Granted Voucher Under FDA National Priority Pilot Program; Shares Up Pre-Bell - MarketScreener
Promising Prospects for Revolution Medicines: Buy Rating Affirmed on Daraxonrasib’s CNPV Designation - TipRanks
Revolution Medicines (RVMD) Receives FDA Voucher for Cancer Trea - GuruFocus
Revolution Medicines awarded voucher for Daraxonrasib by FDA - TipRanks
Revolution Medicines awarded FDA voucher tied to daraxonrasib - Stock Titan
Revolution Medicines Receives FDA Voucher for Daraxonrasib Under National Priority Voucher Pilot Program - Quiver Quantitative
Revolution Medicines Awarded Voucher for Daraxonrasib (RMC-6236) Under FDA Commissioner's National Priority Voucher Pilot Program - The Manila Times
Revolution Medicines Awarded CNPV Voucher for Daraxonrasib | RVMD Stock News - Stock Titan
Revolution Medicines Awarded Voucher for Daraxonrasib - GlobeNewswire
How Revolution Medicines Inc. stock performs in rising dollar environmentQuarterly Portfolio Review & High Return Trade Guides - newser.com
Revolution Medicines (RVMD) Receives New 'Buy' Rating from Stife - GuruFocus
Revolution Medicines (RVMD) Positioned for Growth with Promising Market Potential - GuruFocus
Using data filters to optimize entry into Revolution Medicines Inc. Equity Warrant2025 Top Gainers & Reliable Price Breakout Signals - newser.com
Revolution Medicines, Disc Medicine, Regeneron Stocks Jump After-Hours As FDA Fast-Tracks 9 Drugs Under New Review Program - Stocktwits
Is a relief rally coming for Revolution Medicines Inc. holders2025 Market Trends & Weekly Market Pulse Updates - newser.com
Will Revolution Medicines Inc. outperform the market2025 Biggest Moves & Weekly Watchlist for Hot Stocks - newser.com
How sentiment analysis helps forecast Revolution Medicines Inc. Equity Warrant - newser.com
Measuring Revolution Medicines Inc. Equity Warrant’s beta against major indicesJuly 2025 EndofMonth & Intraday High Probability Alerts - newser.com
How high can Revolution Medicines Inc. Equity Warrant stock go2025 Pullback Review & Capital Efficient Trade Techniques - newser.com
Full technical analysis of Revolution Medicines Inc. Equity Warrant stock - newser.com
Is now a turning point for Revolution Medicines Inc. Equity WarrantJobs Report & Technical Pattern Based Buy Signals - newser.com
Is Revolution Medicines Inc. Equity Warrant forming a reversal patternJuly 2025 WrapUp & Low Volatility Stock Suggestions - newser.com
How analysts rate Revolution Medicines Inc. stock todayMarket Growth Review & Low Risk High Reward Ideas - newser.com
Revolution Medicines (RVMD) Stock Analysis: Unveiling a 56% Potential Upside Amidst Robust Buy Ratings - DirectorsTalk Interviews
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):